Context
Estrogen has proved effective in inhibiting cytomegalovirus (CMV) infection and may protect heart cells from the damaging effects of inflammation. The inflammatory response in the body leads to the production of oxygen free radicals, which can contribute to plaque build-up in the coronary arteries, potentially blocking blood vessels.
Scientists from the National Institute of Health in Bethesda, Maryland, USA, studied smooth muscle cells taken from a premenopausal woman's coronary artery, which were pretreated with different molecular forms of estrogen.
Significant findings 17?-estradiol and its stereoisomer 17a-estradiol dose-dependently inhibited ROS generation in the CMV-infected human coronary artery smooth muscle cells (SMCs). However, the estrogen receptor inhibitor ICI 182780 did not block these effects. In addition, 3-Methoxyestrone, which lacks the phenolic hydroxyl group, did not interfere with ROS generation. 17?-estradiol and 17a-estradiol, but not 3-methoxysterone, also prevented binding of nuclear factor-kB to DNA. CAT activity was inhibited, and in CMV-infected SMCs, IE72 and ICAM-1 protein expression and cytopathic effects were prevented by treatment with 17?-estradiol and 17a but not 3-methoxysterone.
